Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
J. Melville Engle currently holds 416,693 shares of Predictive Oncology Inc. (POAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Melville Engle has been a net buyer of POAI stock. They have purchased $222.8K and sold $0 worth of shares.
J. Melville Engle's most recent insider trade was on Nov 1, 2022, when they sold 213,300 shares at $0.00 per share.
J. Melville Engle serves as Executive at Predictive Oncology Inc. (POAI). They have executed 11 insider transactions totaling $222.8K over their tenure at the company.
J. Melville Engle holds the position of Executive at Predictive Oncology Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
J. Melville Engle has shown a buying trading pattern, with $222.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by J. Melville Engle was on May 24, 2022, when they purchased $59.0K worth of POAI shares. This transaction involved 159,500 shares at $0.37 per share.
J. Melville Engle currently owns 416,693 shares of Predictive Oncology Inc. (POAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of J. Melville Engle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. J. Melville Engle has 11 Form 4 filings on record as an insider at Predictive Oncology Inc..
Set alerts for J. Melville Engle and 40,000+ other insiders.